Gender-dependent differences in uridine 5'-diphospho-glucuronosyltransferase have implications in metabolism and clearance of xenobiotics

By Liu Wei   Kulkarni Kaustubh   Hu Ming  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 12, 2013-12 ,pp. : 1555-1569

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of Uridine Diphosphoglucuronosyltransferase (UGT) 1A Family Members and its Role in Patient Response to Irinotecan*

By Nagar Swati   Blanchard Rebecca  

Drug Metabolism Reviews, Vol. 38, Iss. 3, 2006-06 ,pp. : 393-409

Informa Healthcare

Access to resources Recommend Favorite

VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update

By Eng Lawson   Liu Geoffrey  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1659-1667

Future Medicine

Access to resources Recommend Favorite

Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update

By Anglicheau Dany   Legendre Christophe   Beaune Philippe   Thervet Eric  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 835-849

Future Medicine

Access to resources Recommend Favorite

Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis

By Sicard Michelle N   Zai Clement C   Tiwari Arun K   Souza Renan P   Meltzer Herbert Y   Lieberman Jeffrey A   Kennedy James L   Müller Daniel J  

Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. : 1561-1571

Future Medicine

Access to resources Recommend Favorite